Ascletis Pharma Eulerpool 新闻

Ascletis Pharma Eulerpool-AFX

Ascletis Pharma 股票新闻

Ascletis Pharma受到全球许多记者和投资者的关注。我们在这里整合最新的Ascletis Pharma新闻。

• ·

  Yahoo
  Gannex Announces Poster Presentation of Positive Interim 12-Week Results from Phase II Clinical Trial of ASC41 in Patients with Biopsy-Confirmed MASH at EASL CONGRESS 2024
• ·

  Yahoo
  Ascletis Announces Strategic Decisions on FXR agonist ASC42
• ·

  Yahoo
  Ascletis Announces Poster Presentation of Phase II Study Final Results of FASN Inhibitor ASC40 for Treatment of Acne at 2024 AAD Annual Meeting
• ·

  SeekingAlpha
  Week In Review: Arrivent BioPharma Raises $175M In IPO For In-Licensings From China
• ·

  Yahoo
  Ascletis Announces Dosing of the First Patient in Phase III Clinical Trial of ASC40 (Denifanstat) for Treatment of Acne
• ·

  Yahoo
  Gannex's Strategic Partner Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH
• ·

  Yahoo
  Gannex Announces Positive Interim Results from 52-Week Phase II Clinical Trial of Once-Daily ASC41 Tablet in Patients with Biopsy-Confirmed Non-alcoholic Steatohepatitis
• ·

  Yahoo
  Ascletis Announces Initiation of Phase III Clinical Trial of ASC40 (Denifanstat) for Treatment of Acne
• ·

  Yahoo
  Ascletis Announces Poster Presentations at AASLD Annual Meeting 2023 Including a Late-Breaking Abstract of Interim Results from Phase IIb Expansion Cohort of ASC22 for Functional Cure of CHB
• ·

  Yahoo
  Dr. Jinzi J. Wu Presents at the 10th International Workshop on HBV Cure 2023